Manistee Partners Report issue

For profit Phase 2
Founded: Round Rock TX United States (1996)
Status: Defunct (1998)

Organization Overview

First Clinical Trial
2018
NCT03419715
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Manistee Partners

Active Ingredients

Drugs in Phase 2 Trials (1)

bimatoprost (lumigan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 2)

Headache (Phase 2)

Headache Disorders (Phase 2)

Migraine Disorders (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1